Federal Register #FDA-2026-N-2364

FDA Seeks Public Comment on Advisory Committee Information Collection

This opportunity involves a request for public comment from the Food and Drug Administration (FDA) regarding proposed information collection for advisory committee activities. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - No OEMs or commercial vendors are involved, as this is not a procurement or product solicitation. - Products/Services Requested: - Collection of information related to the nomination and appointment of FDA advisory committee members - Submission of curriculum vitae and letters of recommendation for nominees - Updates to member information - Notable Requirements: - The FDA is seeking public input to improve transparency and public confidence in the advisory committee process - Estimated annual reporting burden is 192 hours, based on 407 nominations and 359 member updates - No products, equipment, or services are being purchased; this is strictly an administrative information collection request

Description

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. This collection supports FDA Advisory Committee administrative activities, which advise or make recommendations on public health matters. The FDA is requesting public comments on this proposed information collection by September 4, 2026. The notice includes details on the nomination and appointment process for advisory committee members and aims to increase transparency and public confidence in the process.

View original listing